Scopus Biopharma Inc (SCPS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SCPS Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Scopus Biopharma Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent0.36
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.13
Total Current Assets0.50
Equipment/Property/Plant Net0.00
Total Assets0.50
Liabilities
Accounts Payable and Accrued Liabilities, Current LI10.91
Other Liabilities, Current0.09
Total Current Liabilities11.00
Total Long-term Debt0.00
Total Liabilities11.00
Stockholders' Equity
Stock Subscriptions Receivable-0.01
Common Stock Value0.04
Additional Paid In Capital Common Stock48.62
Retained Earnings / Accumulated Deficit-58.13
Other Equity0.03
Common Stockholder's Equity-9.45
Non-controlling interests & other-1.05
Total Stockholder's Equity-10.50
Liabilities & Stockholder's Equity0.50
4 historic quarters locked

Sign in to unlock the full Scopus Biopharma Inc balance sheet history.

About Scopus Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001410578-23-001787

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License